Skip to content

Autologous Bone Marrow Concentration for Avascular Necrosis of Femoral Head

The Effect of Autologous Bone Marrow Concentration Combined With Core Decompression for Avascular Necrosis of Femoral Head

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03787329
Enrollment
40
Registered
2018-12-26
Start date
2017-04-14
Completion date
2020-12-31
Last updated
2020-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Avascular Necrosis of Femur, Bone Marrow

Keywords

Femur Head Necrosis, Mesenchymal Stromal Cells, Bone Marrow

Brief summary

This study aims to evaluate the effect of bone marrow concentration on avascular necrosis of femur head by comparing clinical and imaging outcomes between patients receiving core decompression surgery with intraoperative bone marrow concentration and those receiving core decompression surgery only.

Detailed description

Avascular necrosis (AVN) of femoral head is a progressive disease that predominantly affects younger patients. Although the exact pathophysiology of AVN has not yet to be elucidated, the disease is characterized by a vascular insult to the blood supply of the femoral head, which can lead to collapse of the femoral head and subsequent degenerative changes. Mesenchymal stem cells (MSCs) are pluripotent cells that can differentiate into multiple mesenchymal tissues, including tenocytes, chondrocytes and osteoblasts, as well as being a source of multiple growth factors to establish an environment conducive to soft and hard tissue regeneration. As bone marrow concentration has high concentration of mesenchymal stem cells, several studies have applied the autologous bone marrow concentration in halting the progression of AVN of femoral head. However, a higher level of evidence for its use on patients suffering from femoral head avascular necrosis has not been reported. This clinical trial will evaluate and compare the eligible patients who undertake core decompression surgery plus intraoperative bone marrow concentration with those who received core decompression surgery only. All patients will be followed for one year and clinical and imaging outcomes will be compared and analyzed.

Interventions

OTHERCore decompression surgery with bone marrow concentration

Core decompression surgery with bone marrow concentration

OTHERCore decompression surgery

Core decompression surgery only

Sponsors

Aeon Biotechnology Corporation
CollaboratorINDUSTRY
Pei-Yuan Lee, MD
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
30 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Age between 30 and 60 years * With diagnosis of avascular necrosis of femoral head, Stage I - Stage III

Exclusion criteria

* With diagnosis of avascular necrosis of femoral head, Stage VI - Stage VI * With prior history of hip surgery * With current or prior history of trauma or infection at hip * Platelet count \< 50,000/µL * With current diagnosis of coagulopathy * With current or prior history of cancer * With current or prior history of hematological disease * Pregnancy * Patients who will not cooperate with one-year followup

Design outcomes

Primary

MeasureTime frameDescription
3-month postoperative hip function evaluated by Harris Hip Score3-month postoperativeHip function is evaluated using Harris Hip score. The survey has 10 question items and scores range from 0-100 with higher scores representing less dysfunction and better outcomes.

Secondary

MeasureTime frameDescription
12-month postoperative hip function evaluated by Harris Hip Score12-month postoperativeHip function is evaluated using Harris Hip Score. The survey has 10 question items and scores range from 0-100 with higher scores representing less dysfunction and better outcomes.
3-month postoperative degree of collapse evaluated by plain radiograph3-month postoperativeDegree of collapse is evaluated by plain radiograph
6-month postoperative hip function evaluated by Harris Hip Score6-month postoperativeHip function is evaluated using Harris Hip Score. The survey has 10 question items and scores range from 0-100 with higher scores representing less dysfunction and better outcomes.
12-month postoperative degree of collapse evaluated by plain radiograph12-month postoperativeDegree of collapse is evaluated by plain radiograph
6-month postoperative degree of collapse evaluated by MRI6-month postoperativeDegree of collapse is evaluated by MRI
6-month postoperative degree of collapse evaluated by plain radiograph6-month postoperativeDegree of collapse is evaluated by plain radiograph

Countries

Taiwan

Contacts

Primary ContactChang-Han Chuang, MD
skyman889@gmail.com+886-975611794

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026